July 2 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer called multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback